Quince Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2018 | $-3.71 | $-4.63 |
| FY2019 | $-1.94 | $-3.51 |
| FY2020 | $-2.63 | $-3.40 |
| FY2021 | $-3.03 | $-3.43 |
| FY2022 | $-1.54 | $-3.07 |
| FY2023 | $-0.84 | $-2.70 |
| FY2024 | $-1.31 | $-2.51 |
| FY2025 | $-1.68 | $-2.40 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2018 | $-3.71 | $-4.63 |
| FY2019 | $-1.94 | $-3.51 |
| FY2020 | $-2.63 | $-3.40 |
| FY2021 | $-3.03 | $-3.43 |
| FY2022 | $-1.54 | $-3.07 |
| FY2023 | $-0.84 | $-2.70 |
| FY2024 | $-1.31 | $-2.51 |
| FY2025 | $-1.68 | $-2.40 |